Actinium Pharmaceuticals, Inc.

US$1.43As of Sun 8 Nov 2026, 12:00 UTC
AMEX:ATNMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (25.82%)
Div yield —
ROE 45.86%
Biotechnology
Beta (5Y) 0.26
PE TTM 4.018
TSR TTM —
Mkt cap US$44.96M
ROIC 23.00%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.53
7.02%
(74.62%)
Hold 11|5|4|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.04
13.25%
30.54%
27.02%
30.57%
Revenue$M
2.359
2.471
2.450
2.576
0.13%
2.22%
4.31%
10.25%
Peers (US$44.96M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
3.206
0.314
0.267
EBIT/Intx
0.767
0.678
0.617
Own earn%
(46.60)
44.27
47.89
Sh yield%
26.46
38.93
36.07
Owners
Insiders/Inst%
3.64
32.55
Short interest%
3.75
SBC / revenue%
2.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
6–14
$1 testx
—
Incr. ROIC%
22